The clinical utility of gene testing for Alzheimer’s disease
Alzheimer’s disease (AD) is the largest cause of dementia, affecting 35.6 million people in 2010. Amyloid precursor protein, presenilin 1 and presenilin 2 mutations are known to cause familial early-onset AD, whereas apolipoprotein E (APOE) ε4 is a susceptibility gene for late-onset AD. The genes fo...
Main Authors: | Emily R. Atkins, Peter K. Panegyres |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-04-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/ni/article/view/2140 |
Similar Items
-
The Application of Unsupervised Clustering Methods to Alzheimer’s Disease
by: Hany Alashwal, et al.
Published: (2019-05-01) -
EFhd2, a protein linked to Alzheimer’s disease and other neurological disorders
by: Irving E Vega
Published: (2016-03-01) -
Utility of olfactory identification test for diagnosing patients with Alzheimer's disease in Hong Kong.
Published: (1999) -
Counseling following direct to consumer genetic testing for Alzheimer's disease
by: Thomas, Melissa
Published: (2019) -
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
by: Xiaoyan Huang, et al.
Published: (2018-01-01)